Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study

Vikas Gupta, Heidi E. Kosiorek, Adam Mead, Rebecca B. Klisovic, John P. Galvin, Dmitriy Berenzon, Abdulraheem Yacoub, Auro Viswabandya, Ruben A. Mesa, Judith Goldberg, Leah Price, Mohamed E. Salama, Rona Singer Weinberg, Raajit Rampal, Noushin Farnoud, Amylou C. Dueck, John O. Mascarenhas, Ronald Hoffman

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences